6505--Oxybutynin CL SA Tablets
Pre-Solicitation Posted
Not the latest version. See the latest solicitation from .
- Solicitation number
- 36E79725R0062
- Agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Responses due
- Not on record
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Veterans Affairs National Acquisition Center is conducting an unrestricted procurement for Oxybutynin CL SA Tablets through Request for Proposal (RFP) 36E79725R0062. The procurement will serve multiple federal agencies including the VA (including Consolidated Mail Order Pharmacies and State Veterans Homes), Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. Offerors must provide tablets with a unique NDC number and their label must be the only label on the product, with no labels affixed over existing labels. The VA will award one contract to a responsible offeror capable of providing an uninterrupted source of supply, and products will be distributed through the VA and DoD Pharmaceutical Prime Vendor Programs. The solicitation will be issued electronically in commercial item format on or about October 31, 2025, with a tentative closing date of November 14, 2025. The point of contact for this procurement is Chris Carthron, and questions should be directed to Christopher.Carthron@va.gov.
This procurement has no set-aside designation and is open to all responsible sources. The contract structure includes a base period of one year plus four pre-priced one-year option periods, creating a potential five-year total contract duration. The procurement covers five specific configurations of Oxybutynin CL SA tablets in 5mg and 10mg strengths, with package sizes ranging from 100 to 500 bottles per container. The estimated annual requirements range from 11,309 to 30,276 bottles across the different tablet specifications and package configurations. The solicitation falls under NAICS code 325412 (Pharmaceutical Preparation Manufacturing) and will be conducted according to FAR Part 12 commercial item procedures. No incumbent contractor or current provider is identified in the pre-solicitation notice, and no specific award value or budget range is disclosed.
Notice text
PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79725R0062 for an unrestricted procurement for Oxybutynin CL SA Tablets, for the Department of Veterans Affairs (VA) (inclusive of Consolidated Mail Order Pharmacies (CMOPs) and Option 2 State Veterans Homes (SVH)), Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC).
VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs.
Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have an NDC number that is unique to the offeror. The successful offeror/contractor's label with its unique NDC shall be the only label on the product. Contractors shall not affix their label over another label on the product.
Solicitation #36E79725R0062 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about October 31, 2025, with a tentative closing date of November 14, 2025. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check Contracting Opportunities at SAM.gov for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Chris Carthron. Questions can be e-mailed to Christopher.Carthron@va.gov.
The estimated annual requirements are as follows:
REQUIREMENT DESCRIPTION
ITEM
DESCRIPTION
PACKAGE SIZE (Bottles)
TOTAL ESTIMATED ANNUAL USAGE (Bottles)
1
OXYBUTYNIN CL 10MG TAB,SA
100
13,892
2
OXYBUTYNIN CL 10MG TAB,SA
500
16,257
3
OXYBUTYNIN CL 15MG TAB,SA
100
30,276
4
OXYBUTYNIN CL 5MG TAB,SA
100
25,540
5
OXYBUTYNIN CL 5MG TAB,SA
500
11,309
Files
| File | Type | Posted |
|---|---|---|
| 36E79725R0062_1.docx | DOCX document |
Notice history
| Notice | Type | Posted |
|---|---|---|
| 6505--Oxybutynin CL SA Tablets | Solicitation | |
| This notice | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 6505--Sodium Bicarbonate Injection Vial Restricted to Made in America | National Acquisition Center | No set-aside | |
| 6505--Imatinib Tablets | National Acquisition Center | No set-aside | |
| Methylphenidate ER | Medical Supply Chain | No set-aside | |
| Lidocaine 5% patches-request for information | Veterans Integrated Service Network 15 | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity